Current Edition

Uncovering the Temperature-Sensitive Cargo Debate
Labs and Logistics V5 I4

Uncovering the Temperature-Sensitive Cargo Debate

New and updated Good Distribution Practice (GDP) requirements demand that the pharmaceutical industry sits up and takes notice of the importance of a quality assured...
Continue Reading →
The Right Specification for the Laboratory
Labs and Logistics V5 I4

The Right Specification for the Laboratory

Specification and maintenance are important factors to consider when specifying a centralized reverse osmosis (RO) water purification system. Choosing, operating and...
Continue Reading →
Hyaluronic Acid – Creation of Slow Release Formulations for Osteoarthritis Treatments
Clinical Research V5 I4

Hyaluronic Acid – Creation of Slow Release Formulations for Osteoarthritis Treatments

Osteoarthritis (OA) is the world’s most common degenerative joint disorder, affecting more than 60% of the population over the age of 65.During this condition, bone ...
Continue Reading →
A New Future for Antibiotics?
Clinical Research V5 I4

A New Future for Antibiotics?

A future without antibiotics is deemed to be bleak, if bacteria continue to develop new resistance mechanisms and the pharmaceutical industry have to produce novel c...
Continue Reading →
Screening Kidney Function in People With Carotid Artery Disease May Help In Development Of Early Intervention Strategies
Clinical Research V5 I4

Screening Kidney Function in People With Carotid Artery Disease May Help In Development Of Early Intervention Strategies

Chronic kidney disease (CKD) is a progressive reduction in the kidneys’ ability to filter blood. People with CKD have greatly increased mortality risk in comparison ...
Continue Reading →
Proactive Safety Management for Established Healthcare Products
Clinical Research V5 I4

Proactive Safety Management for Established Healthcare Products

A recent analysis shows that more than $290 billion of prescription drug sales are at risk from patent expirations between 2011 and 2018. Chitra Lele at Sciformix di...
Continue Reading →
Critical Thinking on Criticality
Clinical Research V5 I4

Critical Thinking on Criticality

“Critical” is a widely used term in Quality by Design, relating to anything which affects the safety or efficacy of the finished product. Dr. Brian Carlin at FMC Bio...
Continue Reading →
Discovery Toxicology Services
Drug Discovery and Development V5 I4

Discovery Toxicology Services

Toxicology the study of poisons, determines whether a drug can be used on humans. Almost 30% of clinical trial attritions are attributed to the toxicological profile...
Continue Reading →
Improving and Refining Models of Acquired Resistance for Efficient Oncology Drug Discovery
Drug Discovery and Development V5 I4

Improving and Refining Models of Acquired Resistance for Efficient Oncology Drug Discovery

Conventional chemotherapy has been, for many years, the prevalent type of anti-cancer treatment. However its broad-based mechanisms, DNA alkylating agents, usually l...
Continue Reading →
All Eyes on Austria – Vienna Host of the BIO-Europe Conference for a Second Time in only Four Years
REGULATORY AND MARKETPLACE v5 I4

All Eyes on Austria – Vienna Host of the BIO-Europe Conference for a Second Time in only Four Years

Sonja Polan at Life Science Austria explains how the Austrian biotechnology industry is a true success story, as can be seen from the record number, 116, of innovati...
Continue Reading →